Date published: 2025-10-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

1810031K17Rik Activators

1810031K17Rik Activators encompass a diverse array of chemical compounds that serve to indirectly enhance the functional activity of 1810031K17Rik through modulation of specific signaling pathways. For example, Forskolin and Isoproterenol work to augment intracellular cAMP levels, which activates PKA - a kinase that can phosphorylate substrates involved in the pathways that 1810031K17Rik is a part of, thus enhancing its activity. Similar in their indirect effects, Epigallocatechin gallate and Genistein both act as kinase inhibitors, with the potential to relieve 1810031K17Rik from negative regulatory influences and promote its functional role in the cell. PKC activators like Phorbol 12-myristate 13-acetate, and calcium ionophores such as Ionomycin and A23187, further contribute to the enhancement of 1810031K17Rik by modulating signaling pathways related to phosphorylation and calcium-dependent processes, respectively.

Sphingosine-1-phosphate distinctly enhances 1810031K17Rik activity through its receptors, which are involved in various cellular signaling cascades. 1810031K17Rik Activators encompass a diverse array of chemical compounds that serve to indirectly enhance the functional activity of 1810031K17Rik through modulation of specific signaling pathways. For example, Forskolin and Isoproterenol work to augment intracellular cAMP levels, which activates PKA - a kinase that can phosphorylate substrates involved in the pathways that 1810031K17Rik is a part of, thus enhancing its activity. Similar in their indirect effects, Epigallocatechin gallate and Genistein both act as kinase inhibitors, with the potential to relieve 1810031K17Rik from negative regulatory influences and promote its functional role in the cell. PKC activators like Phorbol 12-myristate 13-acetate, and calcium ionophores such as Ionomycin and A23187, further contribute to the enhancement of 1810031K17Rik by modulating signaling pathways related to phosphorylation and calcium-dependent processes, respectively.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

EGCG is a kinase inhibitor known to affect multiple signaling pathways. It could enhance 1810031K17Rik activity by inhibiting kinases that negatively regulate pathways where 1810031K17Rik has a role, thus reducing inhibitory signals and allowing for increased activity.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA is a potent activator of protein kinase C (PKC), which in turn can modulate signaling pathways that involve 1810031K17Rik, potentially enhancing its activity through phosphorylation events.

Ionomycin, free acid

56092-81-0sc-263405
sc-263405A
1 mg
5 mg
$94.00
$259.00
2
(2)

Ionomycin is a calcium ionophore that raises intracellular calcium levels, thereby activating calcium-dependent signaling pathways that could indirectly increase the activity of 1810031K17Rik through downstream effects.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor that can increase the activity of 1810031K17Rik by reducing PI3K/Akt signaling, potentially de-repressing pathways in which 1810031K17Rik is a participant.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$54.00
$128.00
$199.00
$311.00
23
(1)

A23187 is a calcium ionophore that increases intracellular Ca2+ concentration, potentially enhancing the activity of 1810031K17Rik through the activation of calcium-dependent signaling pathways.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$162.00
$316.00
$559.00
$889.00
$1693.00
7
(1)

S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors and may indirectly enhance the activity of 1810031K17Rik by modulating cellular signaling pathways, including those related to cell survival and proliferation in which 1810031K17Rik might be involved.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Staurosporine is a broad-spectrum protein kinase inhibitor that could selectively enhance the activity of 1810031K17Rik by inhibiting kinases that negatively regulate signaling pathways involving 1810031K17Rik.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 is a specific inhibitor of p38 MAP kinase that might enhance the activity of 1810031K17Rik by modulating the cellular stress response pathways and shifting the balance towards pathways that activate 1810031K17Rik.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein is a tyrosine kinase inhibitor that could enhance the activity of 1810031K17Rik by inhibiting competitive signaling pathways and allowing for the activation of pathways where 1810031K17Rik is implicated.